Moderna

MRNA) has announced a $483 million government award to fund manufacturing scale-up and the development of the company’s SARS-CoV-2 vaccine mRNA-1273 to FDA licensure." data-reactid="12" type="text">Biopharma Moderna Inc (MRNA) has announced a $483 million government award to fund manufacturing scale-up and the development of the company’s SARS-CoV-2 vaccine mRNA-1273 to FDA licensure.The NIH-led Phase 1…

Moderna (NASDAQ:MRNA) +10.5% after-hours on news it will receive up to $483M from the U.S. government to accelerate development of a COVID-19 vaccine. The company says the Biomedical Advanced Research and Development Authority within the U.S. Department of Health and Human Services will fund development of the mRNA-1273 vaccine candidate to licensure with the Food…

Published: April 16, 2020 at 6:16 p.m. ET Moderna Inc. MRNA, +8.99% said late Thursday that it will receive up to $483 million from the U.S. government to accelerate development of a COVID-19 vaccine. Shares in Moderna rose 2% in the extended session. The Biomedical Advanced Research and Development Authority within the Department of Health…

MRNA) hosted a virtual vaccines day in which management as well as infectious disease (ID) key opinion leaders (KOLs) highlighted scientific, regulatory and commercial considerations related to Moderna's vaccine programs, including its experimental vaccine against COVID-19, mRNA-1273. With respect to this candidate, Moderna expects to have initial Phase 1 immunogenicity data in the summer, and…